Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Treasury Shares (2021 - 2025)

Oncology Institute (TOI) has disclosed Treasury Shares for 3 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares changed 0.0% year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Sep 2025, changed 0.0%, and an annual FY2024 reading of $1.0 million, changed 0.0% over the prior year.
  • Treasury Shares was $1.7 million for Q3 2025 at Oncology Institute, roughly flat from $1.7 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.3 million in Q2 2023 and bottomed at $794008.0 in Q3 2024.
  • Average Treasury Shares over 5 years is $1.6 million, with a median of $1.7 million recorded in 2024.
  • Peak annual rise in Treasury Shares hit 13.98% in 2024, while the deepest fall reached 0.0% in 2024.
  • Year by year, Treasury Shares stood at $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025.
  • Business Quant data shows Treasury Shares for TOI at $1.0 million in Q3 2025, $1.0 million in Q2 2025, and $1.0 million in Q1 2025.